Regulus Therapeutics Inc.
Methods for treatment of polycystic kidney disease

Abstract:

Provided herein are methods for the treatment of poly-cystic kidney disease, including autosomal dominant polycystic kidney disease, using modified oligonucleotides targeted to miR-17.